focus -WSS

focus

author：focus 2025-08-12 08:29:58 - browse：42347

Rising drug prices —Medicare coverage from STAT — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start. APStock

WASHINGTON — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start.

Medicare released an initial outline of how the program will work in March. Some parts, including the outline of how drugs would be selected for the negotiation process, were immediately final. The agency asked drug companies, patients, and other affected parties to weigh in on other parts about how the process would proceed, what factors would be considered, and how drugmakers would be held accountable.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care

Please enter a valid email address. Privacy Policy

The negotiation process was created last August in Democrats’ drug pricing reform law, and Medicare is supposed to select the first 10 drugs that will be subject to negotiation by Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Astellas still sees hope in its gene therapy after four deaths

focus

WSS

Meta's Zuckerberg and Chan on track to put $50 billion into science

Ransomware attacks on hospitals: Study outlines patient impact

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Eli Lilly to pay $200M for Beam’s stake in gene

Astellas still sees hope in its gene therapy after four deaths

Surge of respiratory disease in China has likely explanation

leisure time

focus

Sign up for D.C. Diagnosis

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

World's first CRISPR

Tori Bowie and the unacceptable rates of Black maternal death

World's first CRISPR

New air purifier tech could be key to improving indoor air quality

Anthos stroke drug appears safer than common blood thinner

Moonlake's readout produced a cash windfall. Risks remain

David Sabatini, ex

Medical records are filled with copy

Testing for cancer recurrence creates a new limbo for patients

knowledge

Traditional Chinese medicine benefits explored in new JAMA study

Congress must reauthorize a committee to support older Americans

Telehealth options flood the market as retailers push virtual care

Diversifying clinical trials isn't enough to close racial gaps: study

FDA's Woodcock to retire early next year

Diversifying clinical trials isn't enough to close racial gaps: study

focus

hotspot

explore

hotspot